600771.SS SHH
GuangYuYuan Chinese Herbal Medicine Co., Ltd.
1W: +0.7%
1M: +2.5%
3M: +1.9%
YTD: -22.1%
1Y: -32.8%
3Y: -56.1%
5Y: -32.2%
¥14.15 ($2.11)
+0.26 (+1.87%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$2.3B
-13.4% ▼
5Y CAGR: -8.4%
Total Liabilities
$685M
-38.9% ▼
5Y CAGR: -9.0%
Shareholders Equity
$1.6B
+4.9% ▲
5Y CAGR: -7.8%
Cash & Investments
$117M
-54.9% ▼
5Y CAGR: -13.3%
Total Debt
$54M
-81.6% ▼
5Y CAGR: -20.9%
Net Debt
-$63M
-293.1% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $394M | $145M | $246M | $259M | $117M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $394M | $145M | $246M | $259M | $117M |
| Net Receivables | $1.9B | $1.5B | $1.1B | $839M | $447M |
| Inventory | $363M | $353M | $415M | $570M | $767M |
| Other Current Assets | $158M | $151M | $0 | $5M | $4M |
| Total Current Assets | $2.8B | $2.1B | $1.8B | $1.7B | $1.4B |
| Property, Plant & Equip. | $770M | $739M | $711M | $707M | $663M |
| Goodwill & Intangibles | $101M | $101M | $99M | $94M | $96M |
| Long-Term Investments | $40M | $38M | $29M | $26M | $20M |
| Other Non-Current Assets | $39M | $39M | $25M | $28M | $33M |
| Total Non-Current Assets | $987M | $977M | $937M | $946M | $908M |
| Total Assets | $3.8B | $3.1B | $2.7B | $2.6B | $2.3B |
| — Liabilities — | |||||
| Accounts Payable | $785M | $489M | $288M | $76M | $73M |
| Short-Term Debt | $310M | $258M | $227M | $252M | $20M |
| Deferred Revenue | $172M | $119M | $43M | $0 | $0 |
| Other Current Liabilities | -$542M | $463K | $346M | $119M | $95M |
| Total Current Liabilities | $1.3B | $873M | $776M | $1.0B | $634M |
| Long-Term Debt | $26M | $70M | $198M | $0 | $0 |
| Other Non-Current Liab. | $10M | $0 | $0 | $9M | $0 |
| Total Non-Current Liabilities | $56M | $88M | $220M | $77M | $51M |
| Total Liabilities | $1.3B | $962M | $996M | $1.1B | $685M |
| — Equity — | |||||
| Common Stock | $492M | $492M | $489M | $489M | $489M |
| Retained Earnings | $304M | -$12M | -$411M | -$609M | -$534M |
| Accumulated OCI | $489M | $492M | $493M | -$3M | $485M |
| Total Stockholders Equity | $2.4B | $2.1B | $1.7B | $1.5B | $1.6B |
| Total Liabilities & Equity | $3.8B | $3.1B | $2.7B | $2.6B | $2.3B |
| — Key Metrics — | |||||
| Total Debt | $336M | $328M | $433M | $291M | $54M |
| Net Debt | -$58M | $183M | $187M | $33M | -$63M |
| Total Investments | $40M | $38M | $29M | $26M | $20M |